1. From Gut Hormone to “Wonder Drug” If you strip...

Strategy and strategic planning are perhaps the most hyped-up...

The pill is now a commodity that many of these companies provide at heavy discounts, making money off everything ‘beyond the pill’. Investors are betting heavily on the potential of technological innovation to transform the way healthcare is delivered. The Economic Times reported that in 2021, India recorded investments of $77 billion across 1,266 deals including 164 large deals worth $58 billion. While the money reduced in 2022, the reason wasn’t a lack of faith in this business model. Meanwhile, the pharmaceuticals industry that is most affected by this quiet but rapid change, is grappling with its entrenched culture. Its current business is so profitable that everything else pales in comparison. ‘Build, measure, learn, build again’ – a mantra of the health tech industry is alien to pharma that doesn’t learn, build or measure after launching a product. Pharma also thinks of its customers as doctors alone and does precious little to connect with patients, or caregivers. People who are not sick do not feature on their radar at all. These are cultural values that keep pharma focused on the pill and discourage thinking beyond it. A social media poll conducted by MedicinMan showed almost predictable responses. 100+ respondents who work in the pharma industry in India were quite clearly divided. 48% of them wanted to know what beyond the pill actually meant, while 23% wanted to know how to execute it. The rest felt that the ultra-competitive environment in the Indian generics market required very high share-of-voice tactics (19%), or that their customers demanded product information (9%).

Part 1: Pharma GCCs in India — Orange Markets...

In our rapidly changing world, adaptability is essential. The strategies and decisions that yielded results yesterday might not be as effective today. By actively engaging with and updating our mental models, we position ourselves to adapt swiftly to evolving circumstances. This ensures our decisions remain timely and anchored in the present.

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

Indian pharmaceuticals have long been known as the “pharmacy...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...